Literature DB >> 16707925

Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents.

Simone Flight1, Lambro Johnson, Manuela Trabi, Patrick Gaffney, Martin Lavin, John de Jersey, Paul Masci.   

Abstract

Textilinin-1 (Q8008) was isolated from the venom of the Pseudonaja textilis and has a 47% sequence identity to the antihaemorrhagic therapeutic agent aprotinin. When equimolar concentrations of enzyme and aprotinin were pre-incubated, plasmin was inhibited 100%, plasma kallikrein 58%, and tissue kallikrein 99%. Under the same conditions, textilinin-1 inhibited plasmin 98%, plasma kallikrein 16% and tissue kallikrein 17%. Whole blood clot lysis was inhibited strongly by both aprotinin and textilinin-1, as shown by thrombelastography. At 2 microM inhibitor lysis initiated by t-PA was greater than 99% inhibited by aprotinin (LY60 = 0.4 +/- 0.1) whereas textilinin-1, inhibited lysis by 91% (LY60 = 8.9 +/- 0.7). The same trend was found with the lysis of euglobulin fractions. From these data textilinin-1 appears to be a more specific plasmin inhibitor than aprotinin but aprotinin inhibits clot lysis to a greater extent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16707925     DOI: 10.1159/000092421

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  11 in total

Review 1.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

2.  Purification and characterization of tenerplasminin-1, a serine peptidase inhibitor with antiplasmin activity from the coral snake (Micrurus tener tener) venom.

Authors:  Jeilyn Vivas; Carlos Ibarra; Ana M Salazar; Ana G C Neves-Ferreira; Elda E Sánchez; Jonás Perales; Alexis Rodríguez-Acosta; Belsy Guerrero
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-09-28       Impact factor: 3.228

3.  Antifibrinolytic role of a bee venom serine protease inhibitor that acts as a plasmin inhibitor.

Authors:  Young Moo Choo; Kwang Sik Lee; Hyung Joo Yoon; Yuling Qiu; Hu Wan; Mi Ri Sohn; Hung Dae Sohn; Byung Rae Jin
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 4.  Brown spider (Loxosceles genus) venom toxins: tools for biological purposes.

Authors:  Olga Meiri Chaim; Dilza Trevisan-Silva; Daniele Chaves-Moreira; Ana Carolina M Wille; Valéria Pereira Ferrer; Fernando Hitomi Matsubara; Oldemir Carlos Mangili; Rafael Bertoni da Silveira; Luiza Helena Gremski; Waldemiro Gremski; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2011-03-22       Impact factor: 4.546

Review 5.  Protease inhibitors from marine venomous animals and their counterparts in terrestrial venomous animals.

Authors:  Caroline B F Mourão; Elisabeth F Schwartz
Journal:  Mar Drugs       Date:  2013-06-14       Impact factor: 5.118

Review 6.  Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise.

Authors:  Julien Slagboom; Jeroen Kool; Robert A Harrison; Nicholas R Casewell
Journal:  Br J Haematol       Date:  2017-02-24       Impact factor: 6.998

Review 7.  Snake Venom Peptides: Tools of Biodiscovery.

Authors:  Aisha Munawar; Syed Abid Ali; Ahmed Akrem; Christian Betzel
Journal:  Toxins (Basel)       Date:  2018-11-14       Impact factor: 4.546

Review 8.  Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Med Res Rev       Date:  2014-03-21       Impact factor: 12.944

9.  The structure of human microplasmin in complex with textilinin-1, an aprotinin-like inhibitor from the Australian brown snake.

Authors:  Emma-Karin I Millers; Lambro A Johnson; Geoff W Birrell; Paul P Masci; Martin F Lavin; John de Jersey; Luke W Guddat
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  A spider-derived Kunitz-type serine protease inhibitor that acts as a plasmin inhibitor and an elastase inhibitor.

Authors:  Hu Wan; Kwang Sik Lee; Bo Yeon Kim; Feng Ming Zou; Hyung Joo Yoon; Yeon Ho Je; Jianhong Li; Byung Rae Jin
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.